Nantahala Capital Management, LLC Ocugen, Inc. Transaction History

Nantahala Capital Management, LLC

  • $1.68 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.83 - $3.45 $30,324 - $57,169
-16,571 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$2.34 - $4.72 $110,061 - $222,005
-47,035 Reduced 73.95%
16,571 $55,000
Q4 2021

Feb 14, 2022
BUY
$4.38 - $15.67 $278,594 - $996,706
63,606 New
63,606 $289,000

Others Institutions Holding OCGN

# of Institutions
125
Shares Held
78.3M
Call Options Held
535K
Put Options Held
523K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $197M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email